Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
01 October 2021
Closing Date:
03 November 2021
Location(s):
PL921 Radomski (PL Poland/POLSKA)
Description:
Purchase and supply of various drugs, pharmaceutical substances and utensylias, Medicines from Drug Programs and nutritional treatment products for the needs of Radom Specialized Hospital.

Purchase and supply of various drugs, pharmaceutical substances and utensylias, Medicines from Drug Programs and nutritional treatment products for the needs of Radom Specialized Hospital.

Various drugs

Various drugs

cd. VI.3

6.LIST OF STATEMENTS OR DOCUMENTS PROVING COMPLIANCE WITH THE CONDITIONS OF PARTICIPATION IN THE PROCEEDINGS AND NO GROUNDS FOR EXCLUSION.

6.1.Each contractor must be joined by:

6.1.1. In order to confirm that the deliveries offered conform to the requirements laid down by the Contracting Authority, the completed technical specification constituting Annexes No 83-161 to this SWZ shall be submitted, in accordance with the part offered.

6.1.2. Completed price form according to the model set out in Annexes Nos 4-82 to SWZ, in accordance with the part offered.

6.1.3. In order to confirm that the deliveries offered conform to the requirements of the Contracting Authority, catalogues confirming the possession of the product offered, the parameters required by the Ordering Party indicated in the description of the item of the contract (Annex 1 to SIVZ) in Part Nos 16-18, 32, 42, 43, 45.47, 63, 64.

In the absence of listing in the catalogue provided by the contractor, the information confirming the fulfilment of the product offered, indicated by the Contracting Authority in/in the parameters, a requirement shall be made to provide the manufacturer's statement in which the manufacturer confirms the possession of the product in/w characteristics required by the Ordering Party in the range.

6.1.4. In order to confirm that the products offered are medicinal products, medical devices or food of special medical use, the offer shall be accompanied by:

a). Declaration by the contractor that medicinal products offered by the contractor are authorised by the Minister of Health or the President of the Medicinal Products, Medical Devices and Biocidal Products Registration Authority or the Council of the European Union or the European Commission to authorise the marketing of the product Therapeutic - affects parts 1-15, 19-31, 33-41, 44, 46, 48-62, 65-68, 72-75.

b) Current declarations of conformity or certificates of conformity or notification to the President of the Office of the Registration of Medicinal Products, Medical Devices and Biocidal Products, in accordance with the Medical Devices Act of May 20, 2010. Journal of Laws of 2020, item 186 of the m./ applies to Part Nos 16-18, 32, 42, 43, 45, 47, 63-64, 69-71

(c) Document confirming the notification to the Chief Sanitary Inspector about the placing for the first time on the market of food for special medical purposes in the territory of the Republic of Poland provided for in Article 29 of the Law of 25 August 2006 on food and nutrition safety (Journal of Laws of U. of 2017, pos. 149 and 60), -applies to parts 76-79.

6.1.5. Power of attorney in the form laid down in SZ 9.12-9.15

6.1.6. The Contracting Authority shall request the submission with the offer of the evidence given in paragraphs 6.1.1, 6.1.3., 6.1.4 to confirm the conformity of the supply offered with the requirements set out in the description of the subject of the contract.

The Contracting Authority shall accept the equivalent measures of evidence in question if they confirm that the deliveries offered meet the requirements laid down by the Contracting Authority.

If the contractor does not submit the measures of evidence in question or the measures of evidence in question are incomplete, the contracting officer shall call for their submission or supplement within the time limit set. The Contracting Authority shall inform that, despite the provision of the summons, he shall not call for the submission or supplement of the evidence in question if the measure in question serves to confirm compliance with the characteristics or criteria set out in the description of the criteria for evaluation of tenders or if, despite submission the tender in question is subject to rejection or there are indications of annulment of the proceedings pursuant to Article 107 (3) of the Law Pzp.

The Contracting Authority may request explanations from the contractors regarding the content of the evidence in question.

cd. II.2.4 part 2

Paracetamolum

Paracetamolum

Darbepoetin alfa

Darbepoetin alfa

Amino acid ketoanalogs

Amino acid ketoanalogs

Heparinum

Heparinum

Miscellaneous drugs III

Miscellaneous drugs III

liquids

liquids

Glycerum - medical device

Glycerum - medical device

Dialysis concentrate - medical device

Dialysis concentrate - medical device

Dialysis concentrate - medical device

Dialysis concentrate - medical device

Miscellaneous IV drugs

Miscellaneous IV drugs

Aciclovir

Aciclovir

cd II.2.4.parts 1

6.1.7 In the event of joint application by contractors, a single document shall be submitted by each of the contractors jointly applying for the contract. These documents confirm the fulfilment of the conditions of participation in the proceedings and the lack of grounds for exclusion to the extent in which each contractor demonstrates compliance with the conditions of participation in the proceedings and the absence of grounds for exclusion.

6.3. Subcontractors

6.3.1. The Contractor in accordance with Article 462 (1) of the Law of Public Procurement Act may entrust the execution of part of the contract to the The Contracting Authority shall request that the Contractor indicate the parts of the contract, the execution of which he intends to entrust to the subcontractor and indicate the names of subcontractors by the Contractor, if they are already known (shall be indicated in the Single European Procurement Document as Annex 3 to the SWZ).

6.4. Before selecting the most favourable tender, the Contractor shall call upon the contractor whose offer has been the highest rated to submit within the specified time limit, not less than 10 days, current at the date of submission of the following statements or documents:

6.4.1 List of statements or documents made by the contractor in the proceedings at the request of the contracting authority to confirm the absence of grounds for exclusion:

(a) current at the date of submission of the declaration in the form of a single European procurement document drawn up in accordance with the model standard form set out in Commission Implementing Regulation (EU) 2016/7 of 5 January 2016. EU No L 3, 6.1.2016, p. 16/, Annex No 3 to SWZ/

NOTE:Part IV ONE: The contractor's eligibility criteria are completed only by Part α.

(b) the allowance or information from the National Court Register or from the Central Records and Business Activities Information drawn up not earlier than 3 months prior to its filing, if separate provisions require entry in the register or records, in order to confirm the absence of grounds for exclusion pursuant to Article 109 (1) (4) of the Pzp Act;

(c) if the Contractor is established or domiciled outside the territory of the Republic of Poland, instead of the documents referred to in:

1) b — files a document or documents issued in the country where the contractor is established or domiciled, confirming that no liquidation has been opened or declared bankrupt.

2) The documents referred to in point 1) should be issued no earlier than 3 months prior to its submission.

3. If, in the country where the contractor is established or domiciled, the documents referred to in point 1 are not issued, they shall be replaced, respectively, in whole or in part, by a document containing the statement of the contractor accordingly, indicating the person or persons entitled to his or her representation, or declaration of the person to whom the document was intended to concern, taken under oath, or, if in the country where the contractor is established or domiciled, there are no provisions of a declaration under oath, made before a judicial or administrative authority, a notary, a body of self-government professional or economic, competent by virtue of the seat or place of residence of the contractor.

(d) In the case of joint application by the contractors for the award of a contract, the contracting authority shall examine whether there is no basis for exclusion against each of those contractors, the documents in point (a) (b) shall be submitted by each of the contractors jointly.

(e) Where the Contractor relies on the capacities or situations of the entities making the resources available, the Contractor shall provide, together with the statement referred to in point 6.4.1.a) of this SWZ, a statement of the resource sharing entity confirming the absence of grounds for exclusion of this the entity and accordingly fulfilling the conditions for participation in the proceedings to the extent that the contractor relies on its resources.

(f) The provisions of point (c) shall apply accordingly to entities providing resources located or domiciled outside the territory of the Republic of Poland.

cd. II.2.4.part 3

Drugs not registered

Drugs not registered

Varicella Zoster import

Varicella Zoster import

Phenobarbital import

Phenobarbital import

Contrast agents I

Contrast agents I

Contrast agents II

Contrast agents II

Contrast agents III

Contrast agents III

Dexamethasoni natrii phosphas

Dexamethasoni natrii phosphas

Methylprednisolonum

Methylprednisolonum

Pantoprazolum

Pantoprazolum

Hydrocortisonum

Hydrocortisonum

Ciprofloxacin

Ciprofloxacin

cd II.2.4.parts 2

6.4.2. List of statements or documents submitted by the contractor in the proceedings at the request of the contracting authority to confirm the conditions of participation in the proceedings:

(a) authorisation for the marketing of medicinal products in accordance with the Act of 6 September 2001 Pharmaceutical Law /t.j. 2020, item 944/ - 1-15, 19-31, 33-41, 44, 46, 48-62, 65-68, 72-75

6.5. Rules for participation in the proceedings of contractors jointly applying for the award of a contract.

6.5.1. Contractors jointly applying for the award of the contract are required to appoint a representative to represent them in the procedure or to represent them in the procedure and conclusion of the public procurement contract. A written power of attorney should be attached to the offer.

6.5.2. Contractors jointly applying for the contract shall be jointly and severally liable for the performance of the contract.

6.5.3. The Employer reserves the right to request Contractors submitting a joint bid to submit to the Employer a contract specifying their mutual relations before concluding the contract.

6.5.4. Contractors jointly applying for the award of the contract shall also mean contractors who are partners in a civil law partnership.

6.6. To the extent not regulated by the SWZ, the provisions of the Regulation of the Minister of Development, Labour and Technology of 23 December 2020 on the means of evidence in question and other documents or statements which may be requested by the contractor /Journal of Laws of 2020, item 2415/

6.7. The Contractor shall not be obliged to make statements or documents proving the absence of grounds for exclusion if the Contracting Party has statements or documents relating to that contractor or may obtain them through free and public databases, in particular public records within the meaning of the Act of 17 February 2005 on the computerisation of the activities of entities carrying out public tasks /i.e., Journal of Laws of 2020, item 346 of the c./ For this purpose, the Contractor shall indicate in the submitted offer the source (address) of the database or procedure where the relevant statements or documents are located in the Contracting Authority.

If the Contractor does not provide in the submitted offer the source (address) of the database or proceedings relating to the writedown or information from the National Court Register or from the Central Registry and Business Information, the Contracting Authority to confirm the absence of grounds for exclusion from the proceedings will benefit from documents found in generally available databases.

6.8. If the contractor does not submit the statements and documents referred to in point 6.3.1. of this SWZ, the statements or documents are incomplete, contain errors, the contracting officer will request their submission, supplement, correction within the time limit indicated, unless despite their submission, the contractor's offer it would be subject to rejection regardless of submission, supplement or correction or invalidation of the proceedings.

Miscellaneous drugs V

Miscellaneous drugs V

Ornitine, Amantadine

Ornitine, Amantadine

Formaldehyde-medical device

Formaldehyde-medical device

Concentrates

Concentrates

Sevofluranum

Sevofluranum

Miscellaneous drugs VI

Miscellaneous drugs VI

Miscellaneous drugs VII

Miscellaneous drugs VII

Miscellaneous drugs VIII

Miscellaneous drugs VIII

Tuberculinic Vaccine

Tuberculinic Vaccine

Umeclidinium + Vilanterol

Umeclidinium + Vilanterol

eptifibatide

eptifibatide

6.2. In the event of joint application by the contractors, the single document shall be submitted by each of the contractors jointly applying for the contract. These documents confirm the fulfilment of the conditions of participation in the proceedings and the lack of grounds for exclusion to the extent in which each contractor demonstrates compliance with the conditions of participation in the proceedings and the absence of grounds for exclusion.

Miscellaneous drugs IX

Miscellaneous drugs IX

Fluconazolum

Fluconazolum

Soda lime - medical device

Soda lime - medical device

Gel with lidocaine/chlorhexidine - medical device

Gel with lidocaine/chlorhexidine - medical device

Kalii chloridum kaps.

Kalii chloridum kaps.

Hemostatic sponges - medical device

Hemostatic sponges - medical device

Levofloxacinum inj.

Levofloxacinum inj.

Sodium citrate-medical device

Sodium citrate-medical device

Metoprolol ZK

Metoprolol ZK

Miscellaneous drugs X

Miscellaneous drugs X

Erythropoietin alpha

Erythropoietin alpha

Immunoglobulinum tetanus

Immunoglobulinum tetanus

Ticagrelol

Ticagrelol

Desfluranum

Desfluranum

Miscellaneous drugs XI

Miscellaneous drugs XI

Amphotericin

Amphotericin

Cerebrolysin

Cerebrolysin

Miscellaneous drugs XII

Miscellaneous drugs XII

Miscellaneous drugs XIII

Miscellaneous drugs XIII

Ondansetron

Ondansetron

Miscellaneous drugs XIV

Miscellaneous drugs XIV

Fondaparinux

Fondaparinux

Miscellaneous drugs XV

Miscellaneous drugs XV

Human immunoglobulin anti- Rh

Human immunoglobulin anti- Rh

Multi-electrolyte fluid

Multi-electrolyte fluid

Wound rinsing preparations containing chlorates. Medical device

Wound rinsing preparations containing chlorates. Medical device

Wound cleaning preparations containing polyhexamide and betaine. Medical device

Wound cleaning preparations containing polyhexamide and betaine. Medical device

SUPERPARINUM CALCICUM

SUPERPARINUM CALCICUM

Immunoglobulin IgA, IgG, IgM

Immunoglobulin IgA, IgG, IgM

Amikacini sulfas

Amikacini sulfas

Pharmaceutical substances

Pharmaceutical substances

Pharmacy fees

Pharmacy fees

Methoxypolyethylene glycol erythropoietin

Methoxypolyethylene glycol erythropoietin

Pharmacy Utensilia I

Pharmacy Utensilia I

Pharmacy Utensilia II

Pharmacy Utensilia II

Parenteral Nutrition I

Parenteral Nutrition I

Parenteral nutrition II

Parenteral nutrition II

Nutrition additives I

Nutrition additives I

Nutrition Additives II

Nutrition Additives II

Enteral Nutrition I

Enteral Nutrition I

Enteral nutrition II

Enteral nutrition II

Nutrition for children

Nutrition for children

Enteral Nutrition III

Enteral Nutrition III

Rocuronium

Rocuronium

Miscellaneous drugs II

Miscellaneous drugs II

Download full details as .pdf
The Buyer:
Radomski Szpital Specjalistyczny im. dr Tytusa Chałubińskiego
CPV Code(s):
15000000 - Food, beverages, tobacco and related products
33140000 - Medical consumables
33600000 - Pharmaceutical products
33651520 - Immunoglobulins
33690000 - Various medicinal products
33692510 - Intravenous fluids
33696000 - Reagents and contrast media
33696500 - Laboratory reagents
39225700 - Bottles, jars and phials